NHI Elects New Director, Robert A. DeLong
Ticker: NHI · Form: 8-K · Filed: Feb 10, 2025 · CIK: 877860
Sentiment: neutral
Topics: board-appointment, governance
Related Tickers: NHI
TL;DR
NHI adds Robert DeLong to the board, effective Feb 7th.
AI Summary
National Health Investors Inc. announced on February 10, 2025, that its Board of Directors has elected Robert A. DeLong as a new director, effective February 7, 2025. DeLong brings extensive experience in healthcare real estate and investment management to the board. The company also disclosed compensatory arrangements for its officers.
Why It Matters
The addition of a new director with relevant industry experience can influence strategic decisions and governance for National Health Investors Inc.
Risk Assessment
Risk Level: low — This filing primarily concerns board appointments and compensatory arrangements, which are routine corporate governance matters.
Key Players & Entities
- National Health Investors Inc. (company) — Registrant
- Robert A. DeLong (person) — Newly elected director
- February 10, 2025 (date) — Date of report
- February 7, 2025 (date) — Effective date of director election
FAQ
Who was elected as a new director for National Health Investors Inc.?
Robert A. DeLong was elected as a new director.
When was Robert A. DeLong's election as a director effective?
The election was effective February 7, 2025.
What is the exact name of the registrant?
The exact name of the registrant is NATIONAL HEALTH INVESTORS INC.
In which state was National Health Investors Inc. incorporated?
National Health Investors Inc. was incorporated in Maryland.
What is the principal executive office address of National Health Investors Inc.?
The principal executive office address is 222 Robert Rose Drive, Murfreesboro, TN 37129.
Filing Stats: 665 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2025-02-10 07:19:07
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value NHI New York Stock Exchange
Filing Documents
- nhi-20250210.htm (8-K) — 26KB
- exhibit991prwebb.htm (EX-99.1) — 11KB
- nhilogoa.jpg (GRAPHIC) — 16KB
- 0000877860-25-000015.txt ( ) — 188KB
- nhi-20250210.xsd (EX-101.SCH) — 2KB
- nhi-20250210_lab.xml (EX-101.LAB) — 22KB
- nhi-20250210_pre.xml (EX-101.PRE) — 13KB
- nhi-20250210_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On February 7, 2025, the Company issued a press release announcing Mr. Webb's resignation from the Board. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibit Index Number Exhibit 99.1 Press Release Titled " NHI Announces Retirement of Robert Webb from the Board of Directors " dated February 7, 2025 in HTML format 104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). .. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. NATIONAL HEALTH INVESTORS, INC. By: /s/ John L. Spaid Name: John L. Spaid Title: Principal Financial Officer Date: February 10, 2025